As the new mutated coronavirus continues to spread, the EU-European Union has announced measures such as support for the development of vaccines specialized for mutated viruses and speeding up approval procedures.
WHO = World Health Organization says that although the number of people newly confirmed to be infected with the new coronavirus is declining in the world, the spread of mutant viruses is continuing.
With the key to dealing with mutant viruses, the EU executive body, the European Commission, announced on the 17th a plan to curb it.
Among them, it includes financial support for testing methods and genome analysis specialized for mutant viruses, development and production increase of vaccines, and speeding up the vaccine approval procedure.
EU Chairman Von der Leyen said, "Science, industry and public institutions can work together to address this challenge," and said that industry-government-academia collaboration is essential. It was.
The EU plans to discuss this measure at an extraordinary online summit next week.
In addition, the European Commission announced on the 17th that it has signed a contract to purchase up to 300 million additional vaccines from the American pharmaceutical company Moderna.
As a result, the EU has secured up to approximately 2.6 billion doses of vaccine.